drugset / Trial / NCT03863535

PRP vs PRP+IVC for Severe nPDR

NCT03863535

RandomizedParallel-groupSingle-blindTreatment

Summary

The randomized clinical trial aims to compare the therapeutic effects between panretinal photocoagulation(PRP) and PRP combined with intravitreal conbercept (IVC) injection in severe nPDR with/without diabetic macular edema patients.

Timeline

Start
2019-01-18
Primary completion
2021-01-01
Completion
2021-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Conbercept Protein / enzyme biologic Intravitreal